Turing’s reviled Shkreli indicted for securities fraud over “Ponzi-like” scheme [Updated] | Ars Technica


$750/pill CEO accused of illegally using assets from former company to pay debts.

Source: Turing’s reviled Shkreli indicted for securities fraud over “Ponzi-like” scheme [Updated] | Ars Technica

$750/pill pharma company under investigation by Senate for price gouging | Ars Technica

Bipartisan committee to probe Turing and its ilk about pricing practices

Source: $750/pill pharma company under investigation by Senate for price gouging | Ars Technica